Skip to main content
. 2018 Nov 28;3(1):159–170. doi: 10.1210/js.2018-00311

Table 2.

Comparison Between Atherosclerosis Measures, Phosphate, and FGF-23 With the Presence of Cardiac Risk Factors

Risk Factors Categorical Variables
CIMT (mm) MPH (mm) TPA (mm2) Phosphate (mmol/L) FGF-23 (RU/mL), Median (IQR)
Diabetes
 Yes 0.81 ± 0.16 3.41 ± 0.97a 71.0 ± 43.7b 1.11 ± 0.23 94.4 (45.0–166.7)a
 No 0.81 ± 0.15 2.77 ± 1.45 48.9 ± 37.3 1.14 ± 0.28 64.4 (45.2–95.8)
Hypertension
 Yes 0.82 ± 0.15 3.07 ± 1.29 58.0 ± 40.4 1.13 ± 0.25 73.1 (47.6–129.7)a
 No 0.78 ± 0.16 2.65 ± 1.49 48.6 ± 40.7 1.11 ± 0.32 56.9 (39.3–92.2)
Dyslipidemia
 Yes 0.82 ± 0.15a 3.17 ± 1.21b 61.1 ± 38.9c 1.14 ± 0.26 71.3 (46.8–125.4)
 No 0.75 ± 0.16 2.02 ± 1.54 30.7 ± 39.7 1.06 ± 0.29 55.7 (44.6–91.7)
Tobacco use
 Yes 0.82 ± 0.15 3.14 ± 1.38 63.8 ± 43.0 1.20 ± 0.20d 95.1 (37.8–146.5)a
 No 0.81 ± 0.15 2.94 ± 1.34 54.2 ± 40.1 1.11 ± 0.28 64.2 (44.6–99.7)
BMI ≥30
 Yes 0.82 ± 0.15 2.96 ± 1.36 59.8 ± 43.1 1.12 ± 0.24 88.5 (53.1–143.6)a
 No 0.81 ± 0.15 2.97 ± 1.34 53.1 ± 38.9 1.13 ± 0.28 61.5 (42.8–93.6)
WC >88 cm (F) and >102 cm (M)
 Yes 0.82 ± 0.16 3.04 ± 1.33 54.7 ± 37.3 1.14 ± 0.26d 82.5 (47.7–133.9)a
 No 0.79 ± 0.15 2.74 ± 1.35 51.8 ± 42.0 1.07 ± 0.29 57.7 (41.7–77.5)
CAD
 Angio. score 1–3 0.82 ± 0.16d 3.17 ± 1.21c 60.9 ± 40.2c 1.15 ± 0.27d 72.1 (46.8–119.0)
 Angio. score 0 0.75 ± 0.12 1.89 ± 1.52 27.8 ± 30.3 1.02 ± 0.23 55.3 (37.2, 95.1)

Abbreviations: CAD, coronary artery disease; MPH, maximum plaque height; WC, waist circumference.

Values are mean ± SD unless noted otherwise. Significance determined with the Wilcoxon test (rank sums).

a

P < 0.01.

b

P < 0.001.

c

P < 0.0001.

d

P < 0.05.